Hepatocellular Carcinoma: Diagnosis and Management
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".
Deadline for manuscript submissions: closed (30 November 2025) | Viewed by 871
Special Issue Editor
2. Department of Nursing, Central Taiwan University of Science and Technology, Taichung 406, Taiwan
Interests: cancer genomics; transcriptomics; personalized medicine; cancer onset and development; cancer biomarkers; diagnostic strategies
Special Issue Information
Dear Colleagues,
Hepatocellular carcinoma (HCC) is the most common type of liver cancer, accounting for ~90% of cases, and is the third leading cause of cancer-related deaths globally. While it has traditionally been diagnosed in its late stages, improved surveillance in patients with cirrhosis and advances in imaging have enabled earlier detection and curative treatment options. Major risk factors include chronic infection with hepatitis B and C viruses, as well as non-alcoholic steatohepatitis (NASH), which is increasingly common in the West and presents a distinct molecular pathogenesis. About 25% of HCCs carry potentially actionable mutations, though their clinical utility remains under investigation. Ultrasound is recommended for the surveillance and follow-up of nodules ≤1 cm, while contrast-enhanced CT or MRI is preferred for nodules >1 cm. Biopsies may be required for atypical lesions but are limited by sampling errors. Subcentimeter lesions should be monitored with repeat imaging and alpha-fetoprotein (AFP) testing every 3–6 months. Accurate diagnosis, proper staging, and timely treatment are vital for improving outcomes. Ongoing research in cancer biomarkers, genomics, transcriptomics, and personalized medicine continues to advance our understanding of HCC and refine diagnostic and therapeutic strategies.
Dr. Po-Ming Chen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hepatocellular carcinoma
- chronic infection
- non-alcoholic steatohepatitis
- diagnostic and therapeutic strategies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
